Children's Heart Institute, Fairfax, Virginia, USA.
Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Heart. 2018 Sep;104(17):1417-1423. doi: 10.1136/heartjnl-2017-312652. Epub 2018 Feb 22.
Surgical coronary revascularisation in children with congenital heart disease (CHD) is a rare event for which limited information is available. In this study, we review the indications and outcomes of surgical coronary revascularisation from the Pediatric Cardiac Care Consortium, a large US-based multicentre registry of interventions for CHD.
This is a retrospective cohort study of children (<18 years old) with CHD who underwent surgical coronary revascularisation between 1982 and 2011. In-hospital mortality and graft patency data were obtained from the registry. Long-term transplant-free survival through 2014 was achieved for patients with adequate identifiers via linkage with the US National Death Index and the Organ Procurement and Transplantation Network.
Coronary revascularisation was accomplished by bypass grafting (n=72, median age 6.8 years, range 3 days-17.4 years) or other operations (n=65, median age 2.6 years, range 5 days-16.7 years) in 137 patients. Most revascularisations were related to the aortic root (61.3%) or coronary anomalies (27.7%), but 10.9% of them were unrelated to either of them. Twenty in-hospital deaths occurred, 70% of them after urgent 'rescue' revascularisation in association with another operation. Long-term outcomes were available by external linkage for 54 patients surviving to hospital discharge (median follow-up time 15.0 years, max follow-up 29.8 years) with a 15-year transplant-free survival of 91% (95% CI 83% to 99%).
Surgical coronary revascularisation can be performed in children with CHD with acceptable immediate and long-term survival. Outcomes are dependent on indication, with the highest mortality in rescue procedures.
先天性心脏病(CHD)患儿的冠状动脉血运重建术较为少见,目前仅有有限的相关信息。本研究回顾了美国大型多中心先天性心脏病介入治疗注册研究组织——儿科心脏护理联盟(PC3)中,冠状动脉血运重建术的适应证和结局。
这是一项回顾性队列研究,纳入了 1982 年至 2011 年期间接受冠状动脉血运重建术的 CHD 患儿(年龄<18 岁)。从注册数据库中获取了住院死亡率和移植物通畅率数据。通过与美国国家死亡指数和器官获取与移植网络进行链接,获得了有足够标识信息的患者在 2014 年的长期无移植生存率。
137 例患者中,72 例行旁路移植术(中位年龄 6.8 岁,范围 3 天至 17.4 岁),65 例行其他手术(中位年龄 2.6 岁,范围 5 天至 16.7 岁)。大多数血运重建与主动脉根部(61.3%)或冠状动脉异常(27.7%)相关,但 10.9%的患者与上述两者均无关。20 例患者在院内死亡,其中 70%在与其他手术相关的紧急“抢救”血运重建后死亡。54 例患者存活至出院并通过外部链接获得了长期结果(中位随访时间 15.0 年,最长随访时间 29.8 年),15 年无移植生存率为 91%(95%CI 83%至 99%)。
CHD 患儿可进行冠状动脉血运重建术,其近期和长期生存率尚可。结局取决于适应证,抢救性手术的死亡率最高。